Medbox Inc. Featured in Wall Street Journal
Article Suggested that Medbox may be an Excellent Investment
HOLLYWOOD, Calif., Nov. 15, 2012 /PRNewswire/ -- Medbox, Inc. (Ticker: MDBX) (www.medboxinc.com), was featured in an article in the MarketWatch section of the Wall Street Journal, which suggested that investing in certain companies right now is similar to getting in on the gold rush at just the right moment.
According to the article, investing in companies that supply services to the legalized medical marijuana industry is being called "The Green Rush," and can provide investors with the means to profit from the fast-growing medical marijuana industry - estimated to be worth about $1.7 billion as of 2011 – without investing in the sale of the drug itself. The article quoted Medbox company founder, Vincent Mehdizadeh, as stating, "The smart money is trying to help with compliance and transparency."
"For regular investors looking to get in on the action — and without having to actually grow or sell drugs — there are several small-cap stocks that stand to gain from marijuana's growing acceptance," the article stated. "Medbox (US:MDBX), an OTC stock with a $45 million market cap, for example, sells its patented dispensing machines to licensed medical-marijuana dispensaries. The machines, which dispense set doses of the drug after verifying patients' identities via fingerprint, could potentially be used in ordinary drugstores, too."
Medbox, which has seen its stock price skyrocket in the past few days, is a leader in providing the industry with tools for increased transparency and compliance – key components to the sector's growth.
"While we are encouraged and extremely excited by the dramatic increase in our stock price, we also believe that supply is simply not meeting demand for our stock, which is in turn boosting the price to never before seen levels," stated Bruce Bedrick, CEO of Medbox, Inc. "Our strong financials, focus on several market niches – including traditional prescription medicine dispensing, and a favorable political environment have all contributed to the strong demand for our company's stock. In the coming months, we will be expanding our shareholder base directly from the company, so that the market demand can be satisfied," he added.
To read the article in the Wall Street Journal, please visit: http://www.marketwatch.com/story/how-to-invest-in-marijuana-2012-11-13?siteid=yhoof2
For more information, contact Medbox Investor Relations at: (800) 762-1452.
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.
Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.
For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.thedispensingsolution.com
SOURCE Medbox, Inc.
More by this Source
Medbox Expands Licensing Agreement with Bio-Tech Medical Software
Mar 06, 2014, 09:00 ET
Medbox To Lobby For Compassionate Care Act And Governor Cuomo's Executive Order
Mar 05, 2014, 16:08 ET
Medbox Appoints Mitch Lowe to Board of Directors
Mar 03, 2014, 11:55 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.